Live feed
Filing
SC 13D/A
SC 13D/A0001072613-20-000244·ARCH Venture Fund IX, L.P.
Schedule 13D ownership disclosure
Vir Biotechnology Inc
Security class unavailable · CUSIP: 92764N102
Event date: 2020-07-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 23.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-20-000244
- Form type
- SC 13D/A
- Filer
- ARCH Venture Fund IX, L.P.
- CIK
- CIK 1666306
- Filed
- Jul 29, 2020
- Reporting period
- Jul 08, 2020
- Description
- Schedule 13D beneficial ownership